A Japanese research team has demonstrated in rat experiments that stem cells from human primary tooth pulp may help treat ...

Japanese government experts endorsed on Thursday ground-breaking projects to manufacture regenerative medicine products to ...

The global stem cell therapy market is projected to experience robust growth, with an expected annual growth rate of 20% by 2029. Key drivers behind this expansion include a favorable investment ...

Chinese scientists have achieved the world’s first reversal of type-2 diabetes using stem-cell therapy. This is no mean feat, ...

Tokyo-based K Pharma Inc. and Nikon Cell Innovation Co. on Tuesday signed a basic agreement on a new clinical trial project using induced pluripotent stem (iPS) cells to treat spinal cord injuries.

Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...